Laser-facilitated epicutaneous immunotherapy with hypoallergenic beta-glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma
E. Korotchenko, V. Schiessl, S. Scheiblhofer, I. Joubert, H. Strandt, T. Neuper, M. Sarajlic, R. Bauer, M. Geppert, D. Joedicke, S. Wildner, S. Schaller, S. Winkler, G. Gadermaier, J. Horejs-Hoeck, R. Weiss
This study shows that LamOVA, a hypoallergenic beta-glucan neoglycoconjugate, suppresses lung inflammation and reduces side effects in a mouse asthma model when delivered via laser-facilitated epicutaneous immunotherapy.
bioRxiv · Jan 18, 2020Immunology